Premium
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
Author(s) -
French Jacqueline,
Kanner Andres M.,
Bautista Jocelyn,
AbouKhalil Bassel,
Browne Thomas,
Harden Cynthia L.,
Theodore William H.,
Bazil Carl,
Stern John,
Schachter Steven C.,
Bergen Donna,
Hirtz Deborah,
Montouris Georgia D.,
Nespeca Mark,
Gidal Barry,
Marks William J.,
Turk William R.,
Fischer James H.,
Bourgeois Blaise,
Wilner Andrew,
Faught R. Edward,
Sachdeo Rajesh C.,
Beydoun Ahmad,
Glauser Tracy A.
Publication year - 2004
Publication title -
epilepsia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.687
H-Index - 191
eISSN - 1528-1167
pISSN - 0013-9580
DOI - 10.1111/j.0013-9580.2004.20041020.x
Subject(s) - neurology , epilepsy , tiagabine , medicine , tolerability , antiepileptic drug , lamotrigine , pediatric neurology , clinical neurology , psychiatry , pediatrics , psychology , pharmacology , neuroscience , adverse effect